NEWS

  • State of the Art: Intrinsic Coagulation Pathway May Yield Therapeutic Targets

    Major strides have been made in understanding the intrinsic coagulation pathway, producing potential new targets for therapies designed to prevent thrombus formation, according to a three-part State of the Art session held Tuesday at the ISTH 2015 Congress. Thrombi induced by medical devices are among the potential targets of effective inhibitors of the intrinsic coagulation …

    READ MORE
  • State of the Art: Longer-acting clotting factor concentrates

    Tuesday morning’s State of the Art session on “longer-acting clotting factor concentrates” highlighted recent advances in therapeutics for hemophilia, with a focus on existing and evolving approaches to treatment. Jerry S. Powell, medical director, coagulation, for CSL Behring, discussed, among other topics,  a factor VIII (FVIII) fusion protein. Andreas Tiede of Hannover Medical School, Germany, …

    READ MORE
  • Why We Miss the Mark on Preventing Cardiovascular Disease

    If you don’t think clinicians should be worried about the current state of cardiovascular disease (CVD) prevention, consider data from the 2011 World Health Organization Global Atlas on CVD Prevention and Control. It found that worldwide, CVD accounts for 31% of deaths: 17.5 million in 2012, projected to increase to 23.3 million in 2030.
    At the …

    READ MORE
  • Advances in Imaging are Helping Researchers Better Understand Immunity

    For more than two decades, Paul Kubes has been studying ways to directly visualize the role of immune cells during inflammation, infection and tissue injury, both in vitro and in vivo.
    During the Tuesday morning J. Fraser Mustard Plenary Lecture at the ISTH 2015 Congress, he discussed several examples of how cutting-edge technologies, such as spinning-disk …

    READ MORE
  • Study Establishes Protocol for Perioperative Discontinuation of Dabigatran 

    In atrial fibrillation (AF) patients who must discontinue dabigatran for elective surgery, the risk of both stroke and major bleeding can be reduced to very low levels using a formalized strategy for stopping and then re-starting anticoagulation, according to results of a prospective study.
    Among key findings presented at a press conference at the ISTH 2015 …

    READ MORE
  • Bayer Hemophilia Awards Program Recognizes Researchers for Nanomedicines, Gene Therapies and Bioengineering Factor VIII

    As part of its commitment to support early-stage research in hemophilia and related bleeding disorders, Bayer HealthCare has awarded Bayer Hemophilia Awards Program (BHAP) grants to clinicians and researchers from six hospitals and research institutions in the United States. BHAP grants will support research into numerous projects, including nanomedicines, new methods to improve inhibitor detection …

    READ MORE
  • ‘Blood clot flash mob’ raises thrombosis awareness

    At first the blood drops “danced” freely through the veins of the exhibit hall, floating and fluttering effortlessly – joyfully, even. They were full of life. ISTH attendees giggled and snapped photos of the spectacle.
    But then things took a turn for the worse. Suddenly, the drops approached a narrow arch, clotting  unexpectedly, piled one on …

    READ MORE
  • Letter from the Editors: Reitsma and Rosendaal recap JTH changes and achievements

    Frits Rosendaal and Pieter Reitsma, editors in chief of the Journal of Thrombosis and Haemostasis, (JTH) describe the changes and achievement of JTH in their Letter from the Editors below:
    We are now in office more than two years. Actually, we took over from Mike Greaves and David Lane in the same year as we organized …

    READ MORE
  • Don’t Miss These Events on Tuesday

    Tuesday features another full day of great events and sessions. See a few highlights below:
    Plenary Session 2 – Paul Kubes
    Platelets and immunity
    9:45-10:30 | Plenary Room
    Lunch Symposia
    Click here to see the list of Tuesday’s Lunch Symposia
    12:15-13:45 | Click here for locations
    Plenary Session 3 – Brian McCrindle
    Why do we miss the mark on preventing cardiovascular disease? Is …

    READ MORE
  • ISTH course on venous thrombosis releases new module: ‘Diagnosis of Venous Thrombosis’

    The ISTH Academy, the Society’s official online education platform, has released a new module, “Diagnosis of Venous Thrombosis,” for the ISTH Course on Venous Thrombosis (VT). The ISTH Course on VT is an accredited course, developed by internationally recognized ISTH experts, and this new module, developed by Philip Wells of the University of Ottawa, is the third component of …

    READ MORE
  • The ISTH releases new Clinical Core Curriculum

    The International Society on Thrombosis and Haemostasis (ISTH) has released the new Clinical Core Curriculum. This Curriculum is a standard endorsed by the Council of the ISTH. The Curriculum offers a framework that promotes the harmonization of training and competency, both clinical and laboratory, by clarifying the requirements for a specialist in the field. Developed …

    READ MORE

PLENARIES

  • Why We Miss the Mark on Preventing Cardiovascular Disease

    If you don’t think clinicians should be worried about the current state of cardiovascular disease (CVD) prevention, consider data from the 2011 World Health Organization Global Atlas on CVD Prevention and Control. It found that worldwide, CVD accounts for 31% of deaths: 17.5 million in 2012, projected to increase to 23.3 million in 2030.
    At the …

    READ MORE
  • Advances in Imaging are Helping Researchers Better Understand Immunity

    For more than two decades, Paul Kubes has been studying ways to directly visualize the role of immune cells during inflammation, infection and tissue injury, both in vitro and in vivo.
    During the Tuesday morning J. Fraser Mustard Plenary Lecture at the ISTH 2015 Congress, he discussed several examples of how cutting-edge technologies, such as spinning-disk …

    READ MORE

SOCIAL

  • ISTH 5K Run Serves up Fun, Raises Funds

    A total of 150 runners and walkers capped off a busy day Tuesday by taking part in the ISTH 2015 5K Fun Run. The evening event, which was sold out, took place along the shore of Lake Ontario and raised funds to support  World Thrombosis Day.
    First to cross the finish line: Geoff Werstuck!
     
     

    READ MORE

STATE-OF-THE-ART

  • State of the Art: Intrinsic Coagulation Pathway May Yield Therapeutic Targets

    Major strides have been made in understanding the intrinsic coagulation pathway, producing potential new targets for therapies designed to prevent thrombus formation, according to a three-part State of the Art session held Tuesday at the ISTH 2015 Congress. Thrombi induced by medical devices are among the potential targets of effective inhibitors of the intrinsic coagulation …

    READ MORE
  • State of the Art: Longer-acting clotting factor concentrates

    Tuesday morning’s State of the Art session on “longer-acting clotting factor concentrates” highlighted recent advances in therapeutics for hemophilia, with a focus on existing and evolving approaches to treatment. Jerry S. Powell, medical director, coagulation, for CSL Behring, discussed, among other topics,  a factor VIII (FVIII) fusion protein. Andreas Tiede of Hannover Medical School, Germany, …

    READ MORE

AWARDS